Please assess the completion status of the following clinical trial:

Trial Title: Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac Surgery

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Undergoing isolated Coronary Artery Bypass Grafting operation or Aortic Valve Repair (AVR).~2. Preoperative Hb \< 7 mmol/l.~Exclusion Criteria:~1. Off pump surgery.~2. Combination surgery.~3. Re-operation.~4. Emergency operation.~5. Patients with bleeding disturbances; e.g, hemophilia and patients with chronic liver disease.~6. Concomitant use of cyclosporine prior to, during or following surgery.~7. Female patients who are pregnant or planning to become pregnant.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Erythropoietin Iron (Type: OTHER): Erythropoietin and iron:~Administration of Erythropoietin (600 IU/kg (14.4 g/L)) twice weekly for three weeks .~Administration of Iron (Ferinject (iron(III)carboxymaltose)) intravenously 1000 mg once.

Based on this trial design, predict the completion outcome and termination type (if applicable).